Therapeutische gebieden

Understanding Disease Modification in Atopic Dermatitis

Understanding Disease Modification in Atopic Dermatitis

Act early, think holistically for your patients with Type 2 diabetes at very high cardiovascular risk

People with type 2 diabetes and atherosclerotic cardiovascular disease face a high risk of cardiovascular events, yet many remain undertreated.¹ The EASD/ADA 2022 and ESC 2023 guidelines for the management of type 2 diabetes urge early insulin initiation and intensive lipid lowering through a holistic approach. Managing both glycemia and lipids together is key to preventing CV events in people with type 2 diabetes.^2,3

Understanding Autoimmune T1D & The Value of Early Detection

Autoimmune Type 1 Diabetes (T1D) can be detected through islet autoantibody testing years before symptoms appear.^1-2 The video here explains how the condition progresses silently through presymptomatic stages, with beta cell destruction occurring long before symptom onset and clinical diagnosis.^4-8

Atopic Dermatitis Control Tool (ADCT)

GO-Doctor: Play, Experience, Learn

Lukt het jou om deze klinische casussen op tijd te diagnosticeren?

Vaccin gerelateerde materialen bestellen

Webinar: Disease Modification in Atopic Dermatitis

Breath Breaks: ERS Lunchsessies 2025

EADV 2025 with Sanofi: Advanced Dermatology Resources

Discover Sanofi at EADV2025 featuring BioDay registry findings, expert panels, and networking opportunities for dermatology professionals in Paris.

On-demand webinar: Redefining Eosinophilic Oesophagitis (EoE) Control

FLUNITY-HD: Results of the pooled analysis of the two individually randomized real-world studies, DANFLU 2 and GALFLU

Monday September 15th, 2025 16:00-17:15 CET

Terugkijken: CRSwNP in Practice: Real Cases, Real Decisions, Real Impact

ERS-ISIAN 2025 (Boedapest, 23 juni 2025).